Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Esophageal Neoplasms × Patient Positioning × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 1

Interventions

Fluorouracil 17 Cisplatin 16 pembrolizumab 12 Radiotherapy 10 Oxaliplatin 10 Irinotecan 8 Paclitaxel 6 Leucovorin 6 Docetaxel 6 Carboplatin 6 Capecitabine 6 Trastuzumab 4 Panitumumab 4 Neoadjuvant Therapy 4 Cyclophosphamide 4 Cetuximab 4 Surgical Procedures, Operative 3 Gefitinib 3 Esophagectomy 3 Celecoxib 3 tegafur-gimeracil-oteracil 2 spartalizumab 2 sodium glycididazole 2 niraparib 2 fludarabine 2 S 1 (combination) 2 Plicamycin 2 Pemetrexed 2 Lapatinib 2 Gemcitabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02157363 2017-10-20

POETRI

Technische Universität Dresden

Phase NA Terminated

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡